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Abstract 
High throughput DNA sequencing is increasingly employed to diagnose single gene 
neurological and neuromuscular disorders. Large volumes of data present new challenges in 
data interpretation and its useful translation into clinical and genetic counselling for families. 
Even when a plausible gene is identified with confidence, interpretation of the clinical 
significance and inheritance pattern of variants can be challenging.  We report our approach to 
evaluating variants in the skeletal muscle chloride channel ClC-1 identified in 223 probands 
with myotonia congenita (MC) as an example of these challenges. Sequencing of CLCN1, the 
gene that encodes CLC-1, is central to the diagnosis of MC.  However, interpreting the 
pathogenicity and inheritance pattern of novel variants is notoriously difficult as both dominant 
and recessive mutations are reported throughout the channel sequence, ClC-1 structure-
function is poorly understood and significant intra- and interfamilial variability in phenotype 
is reported.  
Heterologous expression systems to study functional consequences of CIC-1 variants are 
widely reported to aid the assessment of pathogenicity and inheritance pattern. However, 
heterogeneity of reported analyses does not allow for the systematic correlation of available 
functional and genetic data. We report the systematic evaluation of 95 CIC-1 variants in 223 
probands, the largest reported patient cohort, in which we apply standardised functional 
analyses and correlate this with clinical assessment and inheritance pattern. Such correlation is 
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important to determine if functional data improves the accuracy of variant interpretation and 
likely mode of inheritance. 
Our data provide an evidence-based approach that functional characterisation of ClC-1 
variants improves clinical interpretation of their pathogenicity and inheritance pattern and serve 
as reference for 34 previously unreported and 28 previously uncharacterised CLCN1 variants. 
In addition, we identify novel pathogenic mechanisms and find that variants that alter voltage 
dependence of activation cluster in the first half of the transmembrane domains and variants 
that yield no currents cluster in the second half of the transmembrane domain. None of the 
variants in the intracellular domains were associated with dominant functional features or 
dominant inheritance pattern of MC.
Our data help provide an initial estimate of the anticipated inheritance pattern based on the 
location of a novel variant and shows that systematic functional characterisation can 
significantly refine the assessment of risk of an associated inheritance pattern and consequently 
the clinical and genetic counselling. 
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Introduction  
Myotonia congenita (MC) is the most common skeletal muscle channelopathy.1   It is caused 
by a reduction in the repolarizing chloride current, resulting in an increase in the excitability 
of the muscle membrane,2 leading to a delay in terminating muscle contraction following 
voluntary activity. This manifests clinically as stiffness and rigidity of affected muscles. MC 
has dominant and recessive forms, both caused by mutations in CLCN1 that result in reduced 
function of the encoded skeletal muscle chloride channel ClC-1.3,4 Sequencing of CLCN1 has 
become integral to confirming MC diagnosis following clinical assessment. However, it is 
important that myotonia is not erroneously attributed to an identified CLCN1 variant as 
myotonia can also be caused by Myotonic Dystrophy (DM)- a multisystem and potentially 
lethal disorder, and by gain-of-function mutations of the skeletal muscle sodium channel 
NaV1.4 (encoded by SCN4A). Mutations in distinct myotonia-associated genes (CLCN1, 
SCN4A, DMPK, CNBP) can co-occur in a patient and modify the presentation compared to a 
patient carrying a single gene mutation.5-11
ClC-1 is a homodimer.12,13 Each subunit contains its own chloride-selective pore and is 
composed of 18 intramembrane α-helices (conventionally numbered A to R) organised in two 
topologically related repeats with opposite membrane orientations, and an intracellular domain 
with two cystathionine beta-synthase (CBS) repeats. The chloride selective pores can be gated 
individually or concurrently, in processes known as fast and slow gating respectively. Both 
gates are opened by membrane depolarization. ClC-1 voltage sensitivity arises from the 
interaction of the channel with chloride ions.14-16 
Interpretation of the clinical significance of a ClC-1 variant can be difficult as MC exhibits 
intra- and interfamilial variability in the phenotype, severity and penetrance. In addition, it is 
currently difficult to accurately predict pathogenicity or inheritance of a novel variant based 
purely on the amino acid change and its location in the ClC-1 channel. 
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Functional assessment of mutations associated with MC has revealed that they either reduce 
functional expression or shift the voltage dependence of channel activation towards depolarized 
voltages, thereby reducing the chloride current at physiological voltages. A mutant subunit can 
show dominant negative effects upon co-expression with wild-type (WT) subunits, typically 
by shifting the voltage dependence of activation of the heterodimeric channel to depolarized 
voltages.17,18 Variants that show dominant negative effects in functional expression analysis 
are typically associated with dominant inheritance of MC4,17,18 while variants without dominant 
negative effects are associated with recessive inheritance.19-21 
To enable accurate use of functional data in a clinical diagnostic setting a correlation 
between distinct functional and clinical features needs to be established. This is currently 
complicated by phenotypic variability but also by heterogeneity in the methodology of the 
acquisition of genetic, clinical and functional data that often does not allow direct comparison 
of distinct functional features with the inheritance data between studies. In addition, some 
variants are found in both dominant and recessive pedigrees, suggesting that the correlation 
between functional features and the inheritance pattern is not linear. Finally, in some cases the 
functional data do not match the predicted pathogenicity and inheritance data.22-24 Thus, an 
evidence-based guide for assessment of pathogenicity and inheritance pattern based on specific 
functional features of ClC-1 variants is needed for purposeful clinical and genetic counselling. 
We use functional expression to inform the diagnosis and genetic counselling in patients 
with MC. Here we report analysis of the correlation of the functional properties of 95 distinct 
missense variants with the reported inheritance pattern of 223 probands in a diagnostic service 
setting and assess the implications for the use of functional data to improve genetic counselling 
in MC. 
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The study was conducted as part of a service evaluation of the NHS England Highly 
Specialised Muscle Channelopathy Service at the National Hospital for Neurology and 
Neurosurgery.  No procedures were performed outside of routine clinical care. The oocytes 
were recovered from Xenopus laevis toads in accordance with the Animals (Scientific 
Procedures) Act 1986.
Genetics
The diagnostic molecular genetics laboratory at the National Hospital for Neurology & 
Neurosurgery is the UK national centre for MC genetic testing. Since 2007 this consists of 
sequencing all 23 exons of CLCN1 plus flanking intronic regions, or targeted sequencing of 
specific exons for relatives of individuals in whom variants have already been identified. For 
samples processed prior to 2007, it was routine for initial sequencing to be of mutation hotspots 
only. At least the proband subsequently underwent full sequencing of all CLCN1 exons apart 
from the few circumstances where it was not possible to obtain DNA to do so.  In cases where 
no mutations are found, a single recessive mutation is identified or a homozygous mutation is 
identified, Multiplex Ligation-dependent Probe Amplification is performed to assess for exon 
deletions or duplications. Whenever possible, the inheritance and allelic distribution of the 
variants is investigated by sequencing CLCN1 in family members. Sequencing of SCN4A (full 
gene or hotspots), DM1 and DM2 retest was triggered after a ClC-1 variant was identified if 
the phenotype was atypical or it was uncertain if the CLCN1 variant could account for dominant 
MC. In some samples SCN4A and CLCN1 were screened in parallel. 
DNA was extracted from blood using standard methods. Bidirectional direct DNA 
sequencing was performed using a Big Dye Terminator sequencing kit [Applied Biosystems 
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(ABI)] and a 3730 automated DNA sequencer (ABI). DNA sequences were analysed using 
version 2.5 SeqScape Analysis software (ABI). All 23 CLCN1 exons are compared to larger 
databases including 1000 genomes, dbSNP, ExAC and Exome Variant Server.  
Clinical and genetic assessment of clinical inheritance pattern
The CLCN1 variants in each pedigree were assigned as dominant, recessive or sporadic, 
based on available demographic, clinical, electrophysiological and genetic data that were 
collected from referral forms and/or clinic notes (Supplementary Table 1-3, Table 1-2).  
Dominant variants were single variants sufficient to cause the MC phenotype and associated 
with parent to child transmission.   The inheritance pattern of some dominant variants was 
specified “with variable penetrance” a) when the proband’s parents self-reported as 
asymptomatic but one was found to have the variant and clinical or electrographic myotonia 
on examination or b) in families with no known history of consanguinity, parents self-reported 
as asymptomatic and a nephew, niece, aunt, uncle or half-sibling was reported to be affected.  
Recessive variants were found in homozygosis or compound heterozygosis and associated with 
asymptomatic parents. Sporadic variants were found in isolation in probands with 
asymptomatic parents and no other family history of MC.  
As expected at service level, the phenotyping and genotyping data for family members was 
not always complete. In Supplementary Tables 1-3 we specify if the assessment of inheritance 
pattern was confirmed by segregation of the variant with the clinical symptoms or if it was 
based on reports. When a family history was not available or was insufficient to determine the 
inheritance pattern, the variant is listed as unknown (Supplementary Table 1-3, Table 1-2). 
Some variants were classified as “uncertain pathogenicity” as specified in the Results. 
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Molecular biology
The mutations were introduced into WT CLCN1 cDNA by Quikchange site-directed 
mutagenesis (Agilent).18 Successful mutagenesis was confirmed by sequencing the entire 
insert.  The mRNA was transcribed from MluI linearized vector using mMessageMachine SP6 
kit (Ambion).  
Xenopus laevis oocytes
Oocytes were extracted from adult female Xenopus laevis,25 isolated after incubation with 2 
mg/ml Collagenase Type A (Roche) in OR-2 (in mM): NaCl 82.5, KCl 2, MgCl2 1, HEPES, 
and injected with 2.5 ng WT or mutant mRNA. The heterozygous condition is simulated by 
injecting a 1:1 mixture of WT and mutant mRNA. The oocytes were incubated in Modified 
Barth’s solution (in mM): NaCl 88, KCl 1, MgSO4 1.68, HEPES 10, Ca(NO3)2 0.47, NaHCO3 
2.4, CaCl2 0.41, supplemented with penicillin and streptomycin routinely for 30-72 hrs at 
~15°C before electrophysiological recordings. Each variant was studied in more than one batch 
of oocytes.  
Electrophysiology
Two-electrode voltage clamp experiments were performed using GeneClamp 500B, 
DigiData 1200 or 1550 Interface, and Clampex software (all Axon Instruments) at room 
temperature in ND96 extracellular media (in mM): NaCl 96, KCl 2, MgCl2 1, HEPES 5, CaCl2 
1.8, pH 7.4. Recording electrodes were filled with 3 M KCl and had a tip resistance <1 MΩ. 
Data were filtered at 1 kHz and sampled at 5 kHz. 
From a holding voltage of -80 mV, an activating pre-pulse step to +60 mV for 250 ms was 
applied before test voltage steps ranging from -150 mV to +190 mV in 10 mV increments for 
250 ms, followed by a tail voltage step to -100 mV.  For most cells the same protocol was also 
applied with a holding voltage of -40 mV as well as an additional protocol where the holding 
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voltage was -80 mV and the pre-pulse step taken to -140 mV. These protocols are referred to 
as Vh=-40mV and Vpp=-140mV, respectively.
Data analysis
Data analysis and presentation were prepared using Clampfit (Axon instruments), Origin 
(OriginLab) and Excel (Microsoft) software.
The tail currents were routinely measured 4ms after the test pulse. The current-voltage 
relationship was fitted with Boltzmann equation: I(V)= Imax/(1+exp((V1/2-V)/Vc))+C,  where 
Imax is the amplitude of the fit, C the offset current, V1/2 the voltage at which the current is 
(Imax+C)/2 and Vc the slope factor. We fixed the value of C in the fitting process to the baseline 
current level at the most hyperpolarized voltages. In some cases two Boltzmann equations were 
required to fit the data: I(V)= C+Imax*(A/(1+exp((V1/2(1)-V)/Vc1))+(1-A)/(1+exp((V1/2(2)-
V)/Vc2))), with C and Imax as above while A, V1/2(1), Vc1 and  (1-A), V1/2(2), Vc2 are the fraction, 
the voltage of half-maximal activation and the slope factor of the first and second Boltzmann 
component, respectively. The time constant of activation was assessed by fitting a two-
component exponential equation to data following settling of capacitive transients, and the 
weighted average of time constants is presented.    
Cells without a clear component of activation that could be described with a Boltzmann 
equation and with tail current amplitude <1 µA following a step to +80 mV were considered 
devoid of functional ClC-1 channel expression. 
The data are presented as mean ± standard error of the mean (SEM) unless otherwise stated. 
To assess if clustering of the variants across the functional and structural groups was 
significant, we used a two-tailed Fisher’s test.  
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Data availability
Functional data are available upon reasonable request to the corresponding author. The 
clinical and genetic data are not publicly available.
Results
Genetic and clinical overview of the cohort
Our cohort comprised 223 probands referred for genetic testing for MC in whom CLCN1 
variants were identified. A total of 115 distinct mutations were identified in the cohort, 95 of 
which were missense while 20 were non-missense (truncating, frameshifting, intronic, 
duplications, deletions or silent). The non-missense variants were included in the cohort only 
if they were compound heterozygous with missense mutations.     
A single heterozygous variant was found in 116, homozygous variant in 27 (one with two 
homozygous variants), compound heterozygous variants in 75, and more than two variants in 
five probands (Supplementary Table 1). In total 309 variants (Supplementary Table 1-3), of 
which 263 were missense (Supplementary Table 2), were found in the cohort and were assigned 
an inheritance pattern. For the missense variants this was either dominant (81), sporadic (21) 
or recessive (74) (Supplementary Table 2). For a further 54 missense variants, family history 
was unavailable or insufficient to determine the inheritance pattern. For 33 missense variants 
the assessment of pathogenicity or inheritance was complicated by co-allelic CLCN1 variants, 
the presence of variants in other myotonia-associated genes, by the variant not segregating with 
MC symptoms, or by reported dominant inheritance in compound heterozygous probands 
where it could not be determined which of the variants was associated with dominant 
inheritance. These variants were assigned “with uncertain pathogenicity”. For 50 of the 
missense variants in the cohort with recessive or dominant inheritance pattern the assessment 
was based on both clinical and genetic segregation data and for 105 variants this was based on 
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clinical symptoms only (Supplementary Table 2). Of the 33 pedigrees with dominant 
inheritance and confirmed segregation, 6 met our criteria for variable penetrance 
(Supplementary Table 2). 
Seventy-eight of the variants were found in a single pedigree only (64 missense variants) 
(Supplementary Tables 1-3). The most common variant, G230E, was identified in 40 pedigrees. 
Eight variants were found associated with more than one inheritance pattern (dominant, 
sporadic, recessive), of which three (G285E, F307S and A313T) were associated with both 
recessive and dominant inheritance. The only variant with genetic segregation data available 
to confirm association with both dominant and recessive inheritance was G285E. Variable 
penetrance has been reported previously for G285E.18,19,26 
To our knowledge, 34 of the missense variants have not been previously reported as 
associated with MC and a further 28 have been reported but not functionally characterised.  
Functional assessment and classification of ClC-1 variants 
The effect of the CLCN1 missense variants on ClC-1 channel function was tested in the 
Xenopus laevis oocyte expression system for the 95 missense variants. The V1/2 for WT 
channels was -34.2±0.6 mV (n=308) (Figure 1, Supplementary Table 4). As the V1/2 of cells 
expressing WT channels was variable (standard deviation (SD)= 10.4 mV, range -68.6 mV to 
-7.8 mV), we assigned a cut-off voltage (V1/2 for the WT channel ±1.5*SD= -18.6 mV) to 
decide if the V1/2 was WT-like or pathogenic (Figure 1C). Using this cut-off voltage, the well-
known pathogenic variant F167L with a modest positive shift in the voltage dependence of 
activation27 (V1/2= -17.7 mV, Supplementary Table 4) was classified as pathogenic while 
variants with V1/2 negative to that were not. One variant, H664P, activated at more 
hyperpolarized voltages than 1.5*SD cut-off (Supplementary Table 4). In the absence of loss-
of-function effects this variant was not considered pathogenic. 
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The current amplitude of WT channels was also variable (-6.3±0.2 µA, SD=3.6 µA, range -
0.5 to -30 µA). Twenty-five variants did not show any chloride currents (Supplementary Table 
4) and for five variants with WT-like voltage dependence of activation (A221E, H369P, 
V397D, F413C, E422K) and one variant with shifted voltage dependence of activation 
(W303R) many of the oocytes did not show currents (Figure 1, Supplementary Table 4) and 
the mean amplitude of the currents from those oocytes that yielded currents was less than the 
mean + SD for oocytes expressing WT channels (Figure 1E). Although not displaying complete 
loss-of-function these variants were considered pathogenic by reducing functional expression 
of the channel. 
Most (91/95) of the channel variants could be described as having WT-like features (25 
variants), no or reduced chloride currents (31 variants) or chloride currents with shifted voltage 
dependence of activation (35 variants) (Figure 1, Supplementary Table 4). 
Functional properties of extraordinary ClC-1 variants 
Four variants showed properties that could not be described by reduced current amplitude 
or shifted voltage dependence of activation alone. 
Two variants (L332R and P342L) showed depolarization activated currents but it was 
difficult to describe the voltage dependence of activation with a Boltzmann equation. In 
addition, the tail current amplitude declined when studied with pre-pulses to hyperpolarized 
voltages (VPP= -140 mV) but increased when using a more depolarized holding voltage (Vh=-
40mV) (Figure 2A,D,E). The voltage dependence of activation of WT channels too is clearly 
dependent on the voltage protocol (Figure 2A,C). To compare WT, L332R and P342L 
behaviour the currents for each cell were normalised to the tail current amplitude following a 
voltage step to +100 mV using the Vh=-40mV protocol. In response to a voltage step to 0 mV 
using the VPP= -140 mV protocol the normalised WT channel activity was 58%, but only 31% 
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for L332R and 24% for P342L channels, demonstrating reduced activity for mutant channels 
at physiological voltages (Figure 2D,E). 
Two variants (M485K and R421C) showed currents at hyperpolarized voltages (Figure 2B, 
F). M485K channels also showed depolarization-activated currents but with a voltage 
dependence of activation that was shifted to depolarized voltages (Supplementary Table 4). 
Oocytes expressing R421C channels showed small depolarization-activated currents (mean tail 
current amplitude -1.1±0.1 µA) with shifted voltage dependence of activation (Supplementary 
Table 4). The current amplitude at -120 mV was -1.8±0.3 µA for M485K cells, -0.9±0.2 µA 
for R421C channels but -0.4±0.05 µA for WT cells (Vpp=-140mV protocol).   
Assessment of dominant negative effect of ClC-1 variants 
To simulate the heterozygous condition of the patient and to assess the inheritance pattern 
of the variant, mRNA encoding mutant and WT subunits were co-injected into oocytes (Figure 
3). We indicate the simulated heterozygous condition by adding the suffix “het” to the variant 
name, e.g. F167Lhet.  
Twenty-three of the 31 variants that showed no or reduced currents when expressed alone 
showed currents with WT-like voltage dependence of activation in simulated heterozygous 
conditions (Figure 3E, Supplementary Table 4). The current amplitude in simulated 
heterozygous condition was not reduced much below 50% of current amplitude from oocytes 
expressing WT channels (Figure 3F). 
Eight variants with no or reduced currents as homomers produced currents with altered 
voltage sensitivity of activation upon co-expression (Figure 3B, Supplementary Table 4). The 
voltage dependence of the heterozygous channels was better fit with Boltzmann equation with 
two rather than with one component. The component that activated at more hyperpolarised 
voltages had a V1/2 similar to that of WT channels (Supplementary Table 4), consistent with 
these currents being produced by a mixed population of WT homomers and WT/mutant dimers.   
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For all variants with a shift in the voltage dependence of activation, the V1/2 of the simulated 
heterozygous channel was less positive than that of the homomeric mutant channel, except for 
the F297S variant that showed a greater shift in the V1/2 in simulated heterozygous than in 
homomeric form (Figure 3E, Supplementary Table 4). For 23 variants the V1/2 was positive to 
the voltage set as a cut-off for assigning pathogenicity in homomeric conditions. This suggests 
that in heterozygous conditions the current amplitude is significantly reduced at physiological 
voltages. For 12 variants the voltage dependence in simulated heterozygous conditions was 
WT-like.   
Thus, in total 35 variants that showed pathogenic changes in homomeric condition did not 
show dominant negative effects on channel function in simulated heterozygous condition 
suggesting recessive inheritance, while 31 variants showed a shifted voltage dependence of 
activation, suggesting dominant inheritance.
The voltage dependence of activation of P342Lhet and L332Rhet channels could be fitted 
with a Boltzmann equation and was WT-like (Supplementary Table 4, Figure 3). However, 
when using the Vpp=-140mV protocol the voltage dependence of activation was shifted ~+30 
mV compared to WT, suggesting that the simulated heterozygous form retains an increased 
sensitivity to voltage protocols (Figure 3). The current amplitude at hyperpolarized voltages 
relative to the amplitude at depolarized voltages was larger for M485Khet and R421Chet 
channels compared to WT channels (Figure 3). The voltage dependence of the depolarization-
activated current was shifted for M485Khet and WT-like for R421Chet channels 
(Supplementary Table 4). 
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Correlation of functional properties with inheritance patterns of 
clinical symptoms 
We next analysed how the distinct functional features of the 95 missense variants 
(“Functional” column Table 1-2, Supplementary Table 4) correlates with the inheritance 
pattern assigned by analysing the clinical and genetic features of the 223 probands (“Clinical / 
Genetic” column in Table 1-2, Supplementary Table 2). To ensure equal weight for each 
variant, the variants that were associated with more than one inheritance category were 
assigned a fractional value based on the frequency they appeared in the distinct categories 
(“Clinical / Genetic” column in Table 1-2). For example, A313T was found in twelve probands: 
nine dominant, one sporadic, and one recessive pedigree and in one pedigree the inheritance 
was unknown. It was assigned with 0.75 dominant, 0.083 sporadic, 0.083 recessive and 0.083 
unknown inheritance. 
WT-like functional features suggest the variant is not associated with MC. Accordingly, the 
pathogenicity was uncertain for 39% of these variants and for a further 24% the data were 
insufficient to confirm the inheritance pattern. For only 37% of these variants was clinical data 
sufficient to assess the inheritance pattern: two probands (6%) were sporadic carrying a lone 
heterozygous variant with asymptomatic parents and the remaining variants (31%) were found 
in recessive pedigrees. 
For variants with recessive functional features the family history was available to confirm 
recessive inheritance for 58%. For 28% the inheritance pattern could not be confirmed and for 
11% the association with MC was uncertain. All probands with unknown inheritance pattern 
and all but one of the probands with uncertain association with MC carried compound 
heterozygous CLCN1 variants. Only two variants with recessive functional features were found 
as a lone mutation. G285V was found in heterozygosis in a dominant pedigree with a parent 
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carrying the variant and displaying mild myotonia. DM1, DM2 and SCN4A mutations were 
excluded in the proband.  In another pedigree the association of a lone F167L variant with MC 
was uncertain as it was identified together with a known pathogenic SCN4A variant.
The non-missense variants were compound heterozygous with missense variants as per 
inclusion criteria. Consistently, when the inheritance pattern of clinical symptoms could be 
determined it was always recessive (Supplementary Table 3). Pathogenicity of some of the 
non-missense variants included in this cohort remains to be determined. 
For missense variants with dominant functional features the inheritance pattern was 
dominant for 41%, sporadic for 11%, recessive for 19%, unknown for 21% and uncertain for 
8% of variants. For 8/10 pedigrees where the association with MC was uncertain the inheritance 
was reported dominant but the proband carried two CLCN1 variants and it could not be 
confirmed which variant was dominant. Two other uncertain cases include probands where a 
heterozygous A313V or G285E variant occurred together with a known pathogenic SCN4A 
variant. 
Two of the variants with a mild positive shift in V1/2 in the simulated heterozygous condition 
compared to the cut-off voltage, A313T and P480S (Supplementary Table 4), were identified 
mainly in dominant pedigrees (75% and 50%, respectively). In contrast, all variants with 
shifted voltage dependence of activation in the homomeric condition but WT-like voltage 
dependence in the simulated heterozygous condition were identified in recessive pedigrees. 
This suggests that the cut-off V1/2 value was useful in discerning variants associated with 
recessive inheritance from variants with a risk of dominant inheritance.     
For statistical analysis of the correlation of functional and inheritance data we excluded the 
variants with insufficient information to determine the inheritance pattern (Figure 4). The 
percentage of variants with uncertain association with MC was significantly higher for variants 
with WT-like functional features (51%) than variants with recessive (16%, p<0.05) or 
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dominant (10%, p<0.01) functional features. The percentage of variants with recessive 
inheritance pattern of clinical symptoms was significantly higher for variants with recessive 
functional features (80%) than variants with WT-like (41%, p<0.01) or dominant (24%, 
p<0.001) functional features. The percentage of variants associated with a dominant 
inheritance pattern of clinical symptoms was significantly higher for variants with dominant 
functional features (52%) than variants with WT-like (0%, p<0.001) or recessive (4%, 
p<0.001) functional features.  Sporadic variants showed dominant or WT-like but not recessive 
functional features.    
Variants with prominent loss-of-function following a hyperpolarizing pre-pulse (L332R, 
P342L) were found in pedigrees with sporadic inheritance, suggesting that a single variant may 
be sufficient to cause clinical symptoms. The M485K variant with hyperpolarization-activated 
currents and shifted voltage dependence of depolarization activated currents in the simulated 
heterozygous condition was found in a large pedigree with recessive inheritance. The 
inheritance pattern for R421C with hyperpolarization-activated currents and WT-like 
depolarization activated currents in the simulated heterozygous condition was also recessive, 
with an asymptomatic heterozygous carrier among the parents. F297S, the only variant with 
V1/2 more positive in the simulated heterozygous than in the homomeric condition, was only 
found in dominant pedigrees.  
Alternative pathogenic mechanisms of variants with WT-like 
voltage dependence of activation
More than a quarter of the studied variants show WT-like expression levels and voltage 
dependence of activation, despite being found in patients with clinical features suggestive of 
MC. Accordingly, for many of these variants the association with myotonia was uncertain, but 
in several pedigrees the clinical and genetic data support an association with MC. We 
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investigated if functional features other than current amplitude or voltage dependence of 
activation could indicate alternative pathogenic mechanisms. 
Two variants, A331S and F333L showed a WT-like voltage dependence of activation 
following a depolarizing pre-pulse (Supplementary Table 4). However, both showed clearly 
reduced rates of activation (Figure 5A,B). Consequently, following a hyperpolarizing pre-pulse 
(Vpp=-140mV), the voltage dependence of activation was shifted ~+25 mV compared to WT 
channels (Figure 5C). A331S was found in a proband with P480fs frameshift mutation with 
asymptomatic parents while F333L was found in homozygosis in a pedigree where the parents 
were confirmed heterozygous asymptomatic carriers. These data suggest that slow activation 
may contribute to MC with recessive inheritance.      
 One variant with WT-like voltage dependence of activation, L587V, showed an accelerated 
rate of activation and closing (Figure 5A,D,E). The variant was found in homozygosis in two 
pedigrees with confirmed asymptomatic parents, suggesting that the variant contributes to 
recessive MC. Accelerated closing is a loss-of-function feature that results in reduced 
increment in current amplitude at physiological voltages when switching from hyperpolarizing 
to depolarizing pre-pulse conditions. For WT channels the mean open probability at -60 mV 
increases from 0.17 to 0.47 (276%) when switching from hyperpolarizing (Vpp=-140mV 
protocol) to depolarizing (Vh=-40mV protocol) pre-pulse condition. Respective values for 
L587V are 0.24 (Vpp=-140mV) and 0.31 (Vh=-40mV) (29% increase, p<0.001 for both 
protocols (Mann-Whitney test)). These data indicate that a lack of increase in ClC-1 channel 
activity at physiological voltage following electrical activation of the muscle may contribute 
towards myotonia. 
Discussion
Our functional data for 95 ClC-1 missense variants identified in 223 myotonic probands 
provide strong support for an evidence-based guide for the use of functional data in the 
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diagnosis of MC. Thirty-four of these ClC-1 variants were novel and 28 had not previously 
been functionally characterised, some of which showed new pathogenic mechanisms that have 
implications for understanding the function of the CLC-1 channel. We also identified clustering 
of variants with distinct functional features on the ClC-1 structure.
Variants with WT-like functional features  
Consistent with the lack of detrimental effects in functional analysis, variants with WT-like 
functional features are significantly more likely to have uncertain association with MC 
compared to variants with pathogenic functional features. However, an association with MC is 
not excluded when a variant is functionally WT-like based on voltage dependence and current 
amplitude alone. Other loss-of-function features may contribute, such as alterations in rates of 
channel activation or deactivation (Figure 5) or splicing, as shown for V327Lvariant.28 Another 
variant c.1222A>G (P408A) creates an AG dinucleotide that activates a cryptic acceptor site 
and potentially alters splicing of CLCN1 mRNA (Human Splicing Finder).  Potential splicing 
defects could be assessed by studying patient CLCN1 mRNA or with the minigene assay.29 It 
is also possible that some variants with WT-like functional features but classified as recessive 
(H29P and S70V) are in fact innocuous as they were compound heterozygous with variants 
with dominant functional features (P234T and F307S, respectively). The classification as 
recessive may be a result of variable penetrance of the dominant variants, as shown previously 
for F307S variant. Finally, it is possible that the pathogenic mechanism involves disruption of 
muscle-specific modulation of the channel that cannot be detected in the Xenopus oocyte 
expression system. ClC-1 modulation involves intracellular domains30,31 where many of the 
variants with WT-like functional features are located (Table 1, see below). 
When a variant with WT-like functional feature was associated with MC the inheritance 
pattern was never dominant (Figure 4). However, two variants with WT-like functional features 
(A402V and R669C) were found as a lone mutation in sporadic pedigrees with asymptomatic 
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parents. It remains to be determined if and how these variants with no detectable pathogenicity 
in functional assay are the sole cause of myotonia in these probands.  
Taken together our data suggests that variants with WT-like functional properties carry a 
significant risk of uncertain association with MC and consequently alternative genetic causes 
of myotonia, e.g. SCN4A mutations and DM should be excluded as a priority, particularly when 
a WT-like variant is found in isolation.
Variants with recessive functional features
Variants with recessive functional features were mainly associated with recessive MC 
(Figure 4). In keeping with this, all probands with functionally recessive variants for whom the 
clinical inheritance pattern was unknown had compound heterozygous variants. Only one 
variant (G285V) was found in isolation in a pedigree with dominant family history. The 
mechanism of dominant inheritance of this variant remains to be determined. 
These data suggest that variants with recessive functional properties should be reported as 
recessive and that finding these variants as the sole heterozygous variant should trigger 
investigations into alternative mechanisms of myotonia.        
Variants with dominant functional features
Fifty-two percent of variants with dominant functional features were found in pedigrees with 
dominant inheritance of clinical symptoms (Figure 4B), 14% in heterozygous probands with 
sporadic inheritance of MC and a further 10% in dominant pedigrees although classified with 
“uncertain association with MC” as they were compound heterozygous with another CLCN1 
variant and segregation data was not available to confirm which variant was associated with 
dominant inheritance or with a known pathogenic SCN4A variant. It is likely that the CLCN1 
variants modify the presentation of SCN4A variants in these probands.8-11
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The clinical inheritance of 24% of the functionally dominant variants was recessive. 
Although for most of these variants the shift in the voltage dependence of activation was 
modest, S289I, a variant with one of the largest shifts was found in a recessive pedigree with a 
reportedly asymptomatic parent. Dominant inheritance had variable penetrance in 7% of 
variants, including the most common dominant variant G230E that was found in two apparently 
unaffected individuals. In our cohort variants with dominant functional features had greatly 
increased risk of dominant inheritance compared to those with recessive or WT-like functional 
features. However, it is possible that none of the variants with dominant functional features has 
full clinical penetrance.        
Structure-function considerations
When plotted on the ClC-1 primary structure a disproportionately high number of variants 
(48%) were located in the first of the roughly identical halves of the transmembrane domain 
(TM1) of ClC-1 subunit (helices B-I and the IJ-linker, residues 111-344) but only 19% of 
variants were found in the intracellular N- and C-termini (1-110, 586-988) (Table 1-2, Figure 
6). Seventy-nine percent (37/47) of the variants that shifted the voltage dependence of 
activation in homomeric or simulated heterozygous condition, including the variants with 
extraordinary functional properties, are located in TM1, while a further eight (17%) were on 
the second half of transmembrane domain (TM2) (residues 345-585) and two variants (4%) 
were intracellular (Figure 6A-C). Of the variants with shifted voltage dependence of activation 
in simulated heterozygous condition 84% (26/31) were found on TM1 and the remaining 16% 
on TM2. In contrast, 16/23 (70%) of the variants with recessive functional features without 
shift in voltage dependence of activation in homomeric condition were found on TM2, six in 
TM1 (26%) and a single variant was intracellular. Finally, WT-like variants were 
predominantly found in intracellular termini (60%, 15/25), while five variants were found in 
TM1 and TM2 each. This distinct, predominant distribution of variants with dominant, 
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recessive without shift in voltage dependence of activation as homomers and WT-like 
functional features in TM1, TM2 and intracellular domains, respectively, was significant 
(Figure 6B,C) and helps guide preliminary predictions on functional features and consequently 
on pathogenicity and inheritance pattern of novel variants. However, functional 
characterisation is still necessary as different substitutions of a single residue can have 
drastically different effects (e.g. M485V and M485K).  Nevertheless, it is notable that in our 
cohort none of the variants found in the intracellular domains were associated with dominant 
inheritance or functional features. Therefore, in patients with a lone intracellular ClC-1 variant, 
alternative mechanisms of myotonia should be excluded as a priority.     
TM1 is mainly located towards the intracellular end of the intramembrane domain where 
the chloride ions are found in the selectivity filter pathway (Figure 6D).32 The voltage 
dependence of ClC-1 channel activation is sensitive to Cl- concentration and arises from 
interactions with the channel and the ion.14-16 It is thus likely that the dominant variants 
localised towards the intracellular side shift the voltage dependence of activation by altering 
these interactions. The TM1 also forms most of the subunit interface (Figure 6E), suggesting 
that mutations in one subunit can affect the chloride conducting pathway in the neighbouring 
subunit through this interface.  F297S, the only variant with voltage dependence of activation 
showing larger shift in simulated heterozygous than in homomeric condition, affects a residue 
located at the subunit interface with the main chain of the two F297 residues in close contact 
(Figure 6G). Functional data suggests that a symmetric F297S channel shows a smaller shift in 
voltage dependence of channel activation than a F297/F297S heterodimer and supports the 
notion that the functional effect of a mutation in one subunit is physically transduced to the 
second subunit through the subunit interface (Figure 6G). 
TM2 is located mainly towards the extracellular side of the intramembrane domain, above 
the selectivity filter pathway.  This may explain the lower frequency of variants that shift the 
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voltage dependence of activation. The variants with shifted voltage dependence in TM2 are 
located close to the Cl- ions (P480, G483, V536) or in the proximity of the TM1 of the 
neighbouring subunit (G523, G551, M560) (Figure 6D). TM2 also contains a cluster of 
recessive variants without shift in voltage dependence of activation in homomeric condition 
located above the selectivity filter (Figure 6D). It is not known if these variants reduce channel 
expression or if they prevent the permeation of chloride by obstructing the pathway. Absence 
of significant subunit interface between two TM2s may explain why the effect of a mutation in 
one subunit is not commonly transduced to the neighbouring subunit. 
Mutations that showed currents at hyperpolarized voltages affect the residues R421 and 
M485 located just above the glutamate residue (E232) implicated as an external gate where 
other mutations with similar gating defects are found (Figure 6F).33 In particular R421 forms a 
salt bridge with D136 that when replaced by a glycine conducts hyperpolarization33 activated 
currents. These data imply that residues above the selectivity filter form a gate that prevents 
hyperpolarization activated currents. 
The WT ClC-1 channels exhibit a low activity state (V1/2~-5mV) induced by 
hyperpolarization and a high activity state (V1/2~-45mV) induced by depolarization, thereby 
displaying hysteresis in its voltage dependence. Transition from low to high activity state 
would allow for larger increase of ClC-1 currents at physiological voltages in response to 
prolonged muscle activity compared to a model where ClC-1 channel activity follows a 
constant voltage dependence. The notion that some mutants (L332R and P342L) showed more 
pronounced defects in response to hyperpolarizing pre-conditions suggests that the properties 
of the mutant channels should be assessed using both high and low activity protocols. This idea 
is reinforced by the observation that two mutant channels (A331S and F333L) with reduced 
rate of activation when measured using hyperpolarized pre-pulses showed WT-like voltage 
dependence of activation when studied with protocols that incorporated a depolarizing pre-
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pulse. The unusual voltage dependence of activation of L332R and P342L channels following 
hyperpolarization may be a result of ultraslow activation (Figure 2). All of these variants are 
found in the linker that connects helices I (TM1) and J (TM2) at the extracellular surface of the 
channel. The IJ-linkers of the two subunits are in close contact but the tip of the linker 
(L332/F333L) reaches to proximity of residues important for channel gating (R421) (Figure 
6F). Our data suggest that the IJ-linker is important for determining the rate of channel 
activation. 
One of the variants in our cohort (L587V) showed reduced shift between low to high activity 
states, a feature that can be attributed to accelerated channel opening and closing. L587V was 
found in homozygosis in two MC pedigrees suggesting that the distinct kinetic features 
contribute towards myotonia and that a normal shift from low to high activity state upon 
electrical activation of the muscle may be important for preventing myotonia. The slow 
component of WT-channel closure may be a result of ([Cl-]-dependent) stabilization of the 
open state that shifts the voltage dependence of activation to more hyperpolarized voltages. 
The location of L587 suggests that conformational changes that stabilize the open state occur 
at the intracellular entrance of the selectivity filter pathway (Figure 6G).  
Implications for clinical practice
One aim of this work was to improve the genetic counselling that we can provide to patients. 
The first application of the data is that even without functional characterisation an initial 
approximate, but evidence-based estimate of the risk of an associated dominant inheritance 
pattern can be drawn based on the location of the variant (Figure 6A). In particular, variants 
with dominant functional features are clustered in TM1 and variants with recessive functional 
features without shift in voltage dependence of activation are clustered in TM2. None of the 
variants in intracellular domains in our cohort were associated with dominant family history or 
dominant functional features suggesting that for variants in intracellular domains other causes 
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of myotonia should be excluded as a priority. The location-based estimate can be refined by 
closer investigation of the location in the 3D structure of the ClC-1 channel (Figure 6).32,34 
Second, once functional characterisation is performed, this risk of an associated dominant 
inheritance pattern can be significantly refined (Fig 4). 
Functional assessment of pathogenicity and inheritance for 95 ClC-1 variants found in 223 MC 
pedigrees shows a clear correlation between recessive and dominant functional features with 
respective inheritance patterns of clinical symptoms. It provides strong support and an 
evidence-based guide for the use of functional analysis in the genetic diagnosis and counselling 
of MC. Accurate diagnostic and genetic counselling may help guide the therapeutic strategies 
of patients with MC.35 
We believe our evidence-based guide is translatable to laboratories using the same protocols 
for functional analysis. Laboratories using different protocols will need to perform a correlation 
analysis between functional features and the inheritance pattern of clinical symptoms to 
establish their own criteria to classify the functional features. The data provided in this 
manuscript serves as a reference for the inheritance pattern of 95 variants to help establish such 
correlations.
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Figure legends:
Figure 1. Overview of functional properties of ClC-1 variants. (A) Representative traces of 
WT channel, a variant with WT-like functional features (M646T) and a variant with shifted 
voltage dependence of activation (S289G). From holding voltage of -80 mV, 250 ms pre-pulse 
step to +60 mV, 250 ms test voltage steps from -150 mV to +190 mV in 10 mV increments 
(only traces in response to pulses up to +60 mV are shown) and a tail voltage step to -100 mV 
were applied. Scale bars: 250 ms (x), 3 µA (y). (B) Voltage dependence of activation of WT 
(black), M646T (blue) and S289G (yellow) channels. Current at the beginning of tail voltage 
step was normalised to peak amplitude of the Boltzmann fit for each cell and the mean ± SEM 
normalized current data is shown. Solid lines show fit of Boltzmann equation to mean data. 
(C) Mean V1/2 ± SEM is shown for each variant. If the V1/2 of the variant was depolarized 
relative to the cut-off voltage (WT ± 1.5*standard deviation red dashed vertical line) the variant 
was considered pathogenic. If the V1/2 was to the left of the cut-off it was considered WT-like. 
(D) Representative current traces of a variant (A221E) with minimal ClC-1 currents. Scale bars 
as in (A). (E) Mean ± SEM tail current amplitude of variants with WT-like voltage dependence. 
Red bars show SD of WT current amplitude data. While most variants showed WT-like current 
amplitude, for five variants many cells did not express currents and when the currents were 
detectable the mean amplitude was outside the limits of WT ± SD. These variants were 
considered pathogenic due to reduced expression. Numbers are shown in Supplementary Table 
4.    
Page 31 of 59








ab344/6371181 by guest on 08 O
ctober 2021
Figure 2. Functional properties of variants where the dysfunction could not be 
described by analysis of V1/2 or current amplitude only. (A) Representative current traces 
of WT, L332R and P342L channels. Voltage protocol was as in 1A except that the holding 
voltage was -40 mV (Vh=-40 mV) (top row) or as in 1A but the pre-pulse step was to -140 mV 
(VPP=-140 mV) (bottom row). Scale bars: 250 ms (x), 5 µA (y). (B) Representative current 
traces of R421C and M485K channels. Voltage protocol was as in 1A except that the pre-pulse 
step was to -140 mV. A & B. Traces in response to test pulses up to +60 mV are shown. Scale 
bars: 250 ms (x), 1 µA (R421C) or 3 µA (M485K) (y). (C) Data for WT channels is shown in 
response to test voltages (grey) or to tail voltage (black) using the Vh=-40 mV protocol (solid 
symbols) and VPP=-140 mV protocol (open symbols). Data for each cell is normalised to 
current in response to (grey) or immediately after (black) a voltage step to +100 mV. Only a 
subset of WT cells was analysed (n=18). (D, E) Data for L332R (red) and P342L (blue) is 
shown for Vh=-40 mV (solid) and VPP=-140 mV (open) protocols. Data is normalised as in C. 
N(L332R)=13 and n(P342L)=11. WT data as in C is shown in black. (F) Mean current at the 
end of the test pulse is plotted against the test voltage for R421C (green) (n=19) and M485K 
(n=9) channels. WT data for cells in C is shown in grey. 
Figure 3. Properties of simulated heterozygous mutant channels. (A) Representative 
current traces of WT channels and mutant channels that displayed no currents in homomeric 
condition. In simulated heterozygous condition these either showed currents with WT-like 
(A493Ehet) or shifted (P480Hhet) voltage dependence of activation. Inserts show a zoom to 
first 90 ms of the tail current to illustrate two distinct components of activation for P480Hhet 
channels. Scale bars: 250 ms (x), 3 µA (y). (B) Voltage dependence of activation of WT, 
A493Ehet and P480Hhet channels. The data were normalized as in 1B except for P480Hhet 
where tail currents in individual cells were normalized to peak amplitude of double Boltzmann 
equation. (C) Representative current traces of a variant with shifted voltage dependence of 
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activation in homomeric condition (S289G) co-expressed with WT subunits. Scale bars: 250 
ms (x), 3 µA (y). (D) Voltage dependence of activation of WT (black), S289G (solid red) and 
S289Ghet (open red) channels. (E) V1/2 of simulated heterozygous channels. Mean WT 
data±1.5SD cut-off voltage is shown in red, data in homomeric conditions with solid symbols 
and in simulated heterozygous conditions with open symbols. For variants with no, or reduced 
currents, in homomeric conditions only data in simulated heterozygous condition are shown. 
Variants with V1/2 left of the cut-off voltage were considered recessive, while variants right of 
the cut-off voltage were considered dominant. Data for variants for which two component 
Boltzmann equation was used to describe the voltage dependence are not included. (F) Current 
amplitude of simulated heterozygous variants that in homomeric condition showed no or 
reduced currents and in heterozygous conditions showed WT-like voltage dependence. None 
of the variants suppressed current amplitude to below 50% of WT current amplitude, consistent 
with an absence of dominant negative effects on WT subunit function. (G) Voltage dependence 
of activation of L332Rhet (red) and P342Lhet (blue) channels using the Vh=-40 mV (solid 
symbols) or VPP=-140 mV (open symbols) protocols. While the V1/2 was WT-like using the 
Vh=-40 mV protocol, this was shifted when using the VPP=-140 mV protocol (V1/2(WT)= -
4.4±0.4 mV, n=271, V1/2(L332Rhet)= 27.0±4.1mV, n=8, V1/2(P342L)= 28.4±4.9mV, n=6). (H) 
Voltage dependence of activation of R421Chet (green) and M485Khet (yellow) channels. (I) 
Voltage dependence of currents at the end of the test voltage pulse for R421Chet (green) and 
M485Khet (yellow) measured using the VPP=-140 mV protocol. Data were normalized to peak 
tail current amplitude of the same cell measured using the standard protocol. The normalised 
current data indicates increased currents at hyperpolarized voltages for the simulated 
heterozygous mutant channels compared to WT channels. 
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Figure 4. Correlation of the functional properties with the inheritance pattern of 
clinical symptoms. Bar graph of inheritance patterns of all pedigrees for missense variants 
with WT-like, recessive and dominant functional features. Dominant inheritance pattern is 
indicated in red, sporadic inheritance in yellow and recessive inheritance in blue. Variants with 
uncertain association with clinical symptoms are shown in grey. Variants with unknown 
inheritance pattern are excluded from the Figure.
Figure 5. Alternative pathogenic mechanisms. (A) Representative current traces showing 
time course of activation of WT, A331S, F333L and L587V. Holding voltage was -80 mV, 
responses steps to voltages between -60 mV and +60 mV are shown. (A, D) Scale bars: 50 ms 
(x), 5 µA (y). (B, C). Time constant (B) and voltage dependence (C) of activation for WT 
(black), A331S (blue) and F333L (orange) channel. Solid symbols show data for Vh=-40 mV 
protocol, open symbols for VPP=-140 mV protocol. (D) Representative current traces showing 
time course of deactivation of WT and L587V channels. Holding voltage was -80 mV, traces 
show the time course of closure following pre-pulse to +60 mV for voltage range +50 mV to -
150 mV.  (E, F). Time constants of activation and deactivation (E) and voltage dependence of 
activation (F) for WT (black) and L587V (pink) channels. Solid symbols show data for Vh=-
40 mV protocol, open symbols for VPP=-140 mV protocol.
Figure 6. Mapping of substituted residues (variants) to ClC-1 structure. (A) Two-
dimensional map of variants. Top: ClC-1 intramembrane helices are represented as squares, 
CBS domains as ovals and the connecting loops as lines. Blue indicates TM1, pink TM2, black 
intracellular (IC). Helices B, I, J and R are indicated. Below: Location of all the variants in this 
cohort is shown on top row and location of the variants with distinct functional features is 
specified below. Two rows of recessive variants are shown depending on if the variant in 
homomeric condition shifted voltage dependence (Recessive (shift)) or just reduced functional 
expression (Recessive (no shift)). Outliers include the variants shown in figures 2 and 5. (B) 
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Percentage of variants located in intracellular domains (grey), TM1 (blue) or TM2 (pink) is 
plotted for variants with distinct functional features. (C) Percentage of variants with dominant 
(yellow), recessive (shift) (orange) or recessive (no shift) (red) and WT-like functional features 
(blue) is plotted for variants located in the intracellular domains (IC), TM1 or TM2. (D) 
Mapping variants to TM1s (left, light blue) and TM2 (right, light pink) to ClC-1 structure 
(6COY).22 TMs of both subunits are shown, variants are plotted on both subunits, Cl- are shown 
in black. View is on membrane plane. Cl- ions (black) on left and right graphs are aligned to 
illustrate location of TM2 higher up in membrane plane compared to TM1. Top row shows 
dominant variants in yellow and Recessive (shift) in orange. Bottom row shows Recessive (no 
shift) variants in red. Variants with WT-like functional features are shown in blue. (E) Top row 
shows a view from above membrane plane with the two TM1s (left, light blue) or TM2s (right, 
light pink) shown in cartoon while the other TM is shown in ribbon. On bottom row all variants 
are mapped based on their functional group as in B. Most of subunit interface is formed by the 
two TM1s (top) and most variants that shift voltage dependence of activation at any condition 
are located here. (F) Variants with attenuated activation particularly following hyperpolarized 
pre-pulse (L332 and P342 in red, A331 and F333 in orange) are shown viewed from above the 
membrane plane. These variants are located on IJ-linker (main chain is shown in light green 
spheres) that forms interface with IJ-linker of neighbouring subunit and reaches to proximity 
of variants that showed enhanced currents at hyperpolarized voltage (R421C (magenta) and 
M485K (cyan)). (G) Location of L587V (green) variant that accelerated both opening and 
closing of the channel at the intracellular opening of the selectivity filter pathway. The F297S 
(orange) variant that displayed larger shift in voltage dependence of activation when co-
expressed with WT subunits compared to homomeric F297S channels is also shown. Note that 
the variants mentioned in F or the L587V variant are not shown in B or C. 
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Table 1 Inheritance patterns of variants with WT-like or Recessive functional features
Clinical / GeneticVariant Functional
Dominant Sporadic Recessive Uncertain Unknown
Sum Location
p.His29Pro WT-like - - 1 - - 1 IC
p.Ser70Leu WT-like - - 1 - - 1 IC
p.Arg105Cys WT-like - - - 1 - 1 IC
p.Leu106Val* WT-like - - - 1 - 1 IC
p.Gln154Arg WT-like - - - 1 - 1 TM1
p.Gly222Ser WT-like - - - 1 - 1 TM1
p.Val327Ile WT-like - - - - 2 2 TM1
p.Ala331Ser* WT-like - - 1 - - 1 TM1
p.Phe333Leu* WT-like - - 1 - - 1 TM1
p.Ala402Val WT-like - 1 1 - - 2 TM2
p.Pro408Ala WT-like - - 2 1 3 6 TM2
p.Val456Ile* WT-like - - - - 1 1 TM2
p.Ala493Thr* WT-like - - - - 1 1 TM2
p.Phe494Leu* WT-like - - - 1 - 1 TM2
p.Leu587Val* WT-like - - 2 - - 2 IC
p.Gly594Val* WT-like - - - - 1 1 IC
p.Arg611His* WT-like - - - 1 1 2 IC
p.Met646Thr* WT-like - - 1 - - 1 IC
p.His664Pro* WT-like - - - 1 - 1 IC
p.Arg669Cys WT-like - 1 - - - 1 IC
p.Gly688Arg* WT-like - - - - 1 1 IC
p.Pro744Thr WT-like - - - 1 - 1 IC
p.Thr837Ile* WT-like - - - 1 - 1 IC
p.Val851Met WT-like - - 2 - -. 2 IC
p.Gly898Arg* WT-like - - - 1 - 1 IC
Total WT-like - 2 12 11 10 35
p.Phe167Leu Recessivea - - 7 4 2 13 TM1
p.Gly190Arg Recessiveb - - 3 1 - 4 TM1
p.Leu198Val Recessivea - - - 1 - 1 TM1
p.Ala221Glu* Recessiveb - - 1 - - 1 TM1
p.Gly233Ser Recessiveb - - 1 - - 1 TM1
p.Val273Met Recessivea - - - - 1 1 TM1
p.Gly276Ser Recessivea - - 1 - - 1 TM1
p.Cys277Arg Recessiveb - - 1 - - 1 TM1
p.Gly285Val* Recessiveb 1 - - - - 1 TM1
p.Glu291Lys Recessiveb - - 1 - - 1 TM1
p.Arg317Leu Recessivea - - 1 - - 1 TM1
p.Ala320Val Recessivea - - 1 - - 1 TM1
p.Arg338Gln Recessivea - - 1 - 1 2 TM1
p.Gly355Arg Recessiveb - - 1 - - 1 TM2
p.His369Pro Recessiveb - - - - 1 1 TM2
p.Val397Asp* Recessiveb - - - - 1 1 TM2
p.Phe413Cys Recessiveb - - - - 1 1 TM2
p.Glu422Lys Recessiveb - - - 1 - 1 TM2
p.Trp433Arg Recessiveb - - - - 1 1 TM2
p.Phe463Ile* Recessiveb - - 1 - - 1 TM2
p.Gly483Ser* Recessivea - - 1 - - 1 TM2
p.Met485Val Recessiveb - - 6 4 1 11 TM2
p.Ala493Glu Recessiveb - - 1 - - 1 TM2
p.Glu500Lys* Recessiveb - - 1 - - 1 TM2
p.Pro521Thr* Recessiveb - - 1 - - 1 TM2
p.Ala529Val* Recessiveb - - - - 1 1 TM2
p.Glu548Lys Recessiveb - - - - 1 1 TM2
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p.Thr550Met Recessiveb - - - 1 - 1 TM2
p.Pro558Ser Recessiveb - - 2 - - 2 TM2
p.Met560Thr Recessivea - - - - 1 1 TM2
p.Ala566Thr Recessiveb - - 2 - - 2 TM2
p.Gln583Arg* Recessivea - - 1 - 1 2 TM2
p.Val640Phe* Recessiveb - - 1 - - 1 IC
p.Asp822Asn* Recessivea - - 1 - - 1 IC
p.Pro883Thr Recessivea - - 1 - 2 3 IC
Total Recessive 1 - 38 12 15 66
Asterisks following variant name indicate variants not reported in the literature previously. Functional = classification 
according to functional feature; Clinical/Genetic = number of pedigrees with distinct inheritance patterns of clinical symptoms. 
Location = if the variant is found in intracellular domain (IC: residues 1–110, 586–988), first (TM1: residues 111–344) or 
second (TM2: residues 345–585) of the transmembrane repeats. Data for the variants that were not missense are presented in 
Supplementary Table 3.
a,bFor recessive variants it is specified if the variant in homomeric condition expresses currents with shifted voltage 
dependence of activationa or reduced current amplitudeb.  
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Table 2 Inheritance patterns of variants with Dominant or Extraordinary functional features
Clinical / GeneticVariant Functional
Dominant Sporadic Recessive Uncertain Unknown
Sum Location
p.Met128Ile Dominant 2 - - - - 2 TM1
p.Cys179Tyr* Dominant 1 - - - - 1 TM1
p.Ser183Pro Dominant 1 - - - - 1 TM1
p.Gly190Ser Dominant - - 3 - - 3 TM1
p.Leu198Pro Dominant - - - - 1 1 TM1
p.Gly200Glu* Dominant - - 1 - - 1 TM1
p.Ala218Val Dominant 1 - - - - 1 TM1
p.Gly230Glu Dominant 29 5 - 1 5 40 TM1
p.Pro234Thr* Dominant - - 1 - - 1 TM1
p.Pro234Leu* Dominant - - - 1 - 1 TM1
p.Thr268Met Dominant 1 - - - 2 3 TM1
p.Cys271Arg Dominant 1 - - - - 1 TM1
p.Gly276Asp Dominant 2 - - - - 2 TM1
p.Gly285Glu Dominant 5 3 9 4 5 26 TM1
p.Ser289Gly* Dominant 1 - - - - 1 TM1
p.Ser289Asn Dominant 1 1 - - - 2 TM1
p.Ser289Ile* Dominant - - 1 - - 1 TM1
p.Phe297Ser Dominant 7 - - - - 7 TM1
p.Val299Leu Dominant - - 2 - - 2 TM1
p.Trp303Arg Dominant 12 2 - - 2 16 TM1
p.Phe306Leu Dominant 2 1 - - 2 5 TM1
p.Phe307Ser Dominant 1 2 4 - 3 10 TM1
p.Ala313Thr Dominant 9 1 1 - 1 12 TM1
p.Ala313Val Dominant 2 - - 2 1 5 TM1
p.Val321Leu Dominant - 1 - - - 1 TM1
p.Thr328Ile Dominant 1 - - - 4 5 TM1
p.Pro480His Dominant - - - 2 - 2 TM2
p.Pro480Ser Dominant 1 - - - 1 2 TM2
p.Gly523Asp Dominant - 1 - - - 1 TM2
p.Val536Ile Dominant - - - - 1 1 TM2
p.Gly551Asp Dominant - - - - 1 1 TM2
Total Dominant 80 17 22 10 29 158
p.Leu332Arg* Other - 1 - - - 1 TM1
p.Pro342Leu* Other - 1 - - - 1 TM1
p.Arg421Cys Other - - 1 - - 1 TM2
p.Met485Lys* Other - - 1 - - 1 TM2
Total All 81 21 74 33 54 263
Asterisks following variant name indicate variants not reported in the literature previously. Functional = classification 
according to functional feature; Clinical/Genetic = number of pedigrees with distinct inheritance patterns of clinical symptoms. 
Location = if the variant is found in intracellular domain (IC: residues 1–110, 586–988), first (TM1: residues 111–344) or 
second (TM2: residues 345–585) of the transmembrane repeats. ‘Other’ indicates that the functional features could not be 
classified as WT-like, dominant or recessive. Data on row ‘All’ includes data from Tables 1 and 2.   
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